Edition:
United States

Hemispherx Biopharma Inc (HEB.A)

HEB.A on American Stock Exchange

0.33USD
11:29am EDT
Change (% chg)

$0.00 (+1.15%)
Prev Close
$0.33
Open
$0.33
Day's High
$0.34
Day's Low
$0.33
Volume
6,223
Avg. Vol
25,609
52-wk High
$1.36
52-wk Low
$0.30

Select another date:

Tue, Aug 29 2017

BRIEF-Hemispherx Biopharma Co's board has reviewed financial condition of company and anticipated needs of company to pursue its goals

* Co's board has reviewed financial condition of company and anticipated needs of company to pursue its goals

BRIEF-Hemispherx Biopharma announces corporate progress and financial results for the 6 months ended June 30 '17

* Hemispherx Biopharma announces corporate progress and financial results for the six months ended June 30, 2017

BRIEF-Hemispherx Biopharma updates on study of Ampligen

* Hemispherx human safety study of intranasal Ampligen with influenza vaccine shows Ampligen was generally well-tolerated ‍​

BRIEF-Hemispherx Biopharma updates status of immuno-oncology program in pancreatic cancer

* Hemispherx updates status of immuno-oncology program in pancreatic cancer

BRIEF-Hemispherx Biopharma announces quarterly loss per share $0.11

* Hemispherx Biopharma announces financial results for the three months ended March 31, 2017

Select another date: